[Prolonged survival in erythroleukemia].
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy / Q000401:mortality*; D008297:Male; D011379:Prognosis
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents